Our research work discovered that for the central nervous regulation of sympathetic activity and blood pressure in PVN, p-ERK1/2 was also essential in bridging RAS activation and hypertension development; while the increase of p-p38 appeared only the concomitant consequence but not the decisive factor. This evidence concerns the gene MAPK3 and hypertensive disorder.